<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gerald LB</submitter><funding>national heart, lung, and blood institute</funding><funding>maternal and child health bureau</funding><funding>NHLBI NIH HHS</funding><pagination>179</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8474899</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>While using an inhaled corticosteroid (ICS) in the weeks after an ED visit reduces repeat visits, few children receive a needed prescription. Because a prescription may not be filled or used, dispensing ICS at discharge and supervising its use at school could overcome both barriers until follow-up care is established. To assess the feasibility of such an intervention, we conducted a pilot study among elementary-age school children with persistent asthma who were discharged from the ED following an asthma exacerbation.&lt;h4>Methods&lt;/h4>Eligible children were randomly assigned to ED-dispensing of ICS with home supervision or ED-dispensing of ICS with home and school supervision. The primary outcomes were ability to recruit and retain participants, ability to initiate school-</pubmed_abstract><journal>Pilot and feasibility studies</journal><pubmed_title>Randomized trial of the feasibility of ED-initiated school-based asthma medication supervision (ED-SAMS).</pubmed_title><pmcid>PMC8474899</pmcid><funding_grant_id>R34 HL137851</funding_grant_id><funding_grant_id>1R34HL137851</funding_grant_id><pubmed_authors>Guthrie CC</pubmed_authors><pubmed_authors>Klein EJ</pubmed_authors><pubmed_authors>Gerald JK</pubmed_authors><pubmed_authors>Denninghoff K</pubmed_authors><pubmed_authors>Startup E</pubmed_authors><pubmed_authors>Lowe A</pubmed_authors><pubmed_authors>Morrison A</pubmed_authors><pubmed_authors>Gerald LB</pubmed_authors><pubmed_authors>VanBuren JM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Randomized trial of the feasibility of ED-initiated school-based asthma medication supervision (ED-SAMS).</name><description>&lt;h4>Background&lt;/h4>While using an inhaled corticosteroid (ICS) in the weeks after an ED visit reduces repeat visits, few children receive a needed prescription. Because a prescription may not be filled or used, dispensing ICS at discharge and supervising its use at school could overcome both barriers until follow-up care is established. To assess the feasibility of such an intervention, we conducted a pilot study among elementary-age school children with persistent asthma who were discharged from the ED following an asthma exacerbation.&lt;h4>Methods&lt;/h4>Eligible children were randomly assigned to ED-dispensing of ICS with home supervision or ED-dispensing of ICS with home and school supervision. The primary outcomes were ability to recruit and retain participants, ability to initiate school-</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-26T00:43:28.18Z</modification><creation>2022-02-11T11:38:10.76Z</creation></dates><accession>S-EPMC8474899</accession><cross_references><pubmed>34579785</pubmed><doi>10.1186/s40814-021-00913-0</doi></cross_references></HashMap>